Being a Parkinson’s disease sufferer, and previously having prostate cancer, Andrew Grove knows all to well the ins and outs of hospital life. That’s partly why the ex-CEO and chairman of Intel has pumped money into “translational medicine” research.
The University of California campuses at Berkeley and San Francisco will be able to use Grove’s generous investment to kick-start a new master’s degree program, fusing engineering and medical research together in the aim of discovering drugs—and with any luck, cures—for aiding patients’ health. [NY Times]
Image Credit: Heinz Awards
